280 related articles for article (PubMed ID: 14734754)
21. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care.
Nooh MM; Nookala S; Kansal R; Kotb M
J Immunol; 2011 Mar; 186(5):3156-63. PubMed ID: 21282506
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SpeA) and the human T-cell receptor.
Kline JB; Collins CM
Mol Microbiol; 1997 Apr; 24(1):191-202. PubMed ID: 9140976
[TBL] [Abstract][Full Text] [Related]
23. Concomitant Disruption of
Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
Rajagopalan G; Smart MK; Krco CJ; David CS
J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Collins CM; Gutman DM; Kline JB; O'Brien SM; Tranter HS; Acharya KR
EMBO J; 1999 Jan; 18(1):9-21. PubMed ID: 9878045
[TBL] [Abstract][Full Text] [Related]
26. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis.
Nooh MM; El-Gengehi N; Kansal R; David CS; Kotb M
J Immunol; 2007 Mar; 178(5):3076-83. PubMed ID: 17312154
[TBL] [Abstract][Full Text] [Related]
27. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of novel superantigens from Streptococcus pyogenes.
Proft T; Moffatt SL; Berkahn CJ; Fraser JD
J Exp Med; 1999 Jan; 189(1):89-102. PubMed ID: 9874566
[TBL] [Abstract][Full Text] [Related]
29. Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.
Rikiishi H; Okamoto S; Sugawara S; Tamura K; Liu ZX; Kumagai K
Immunology; 1997 Jul; 91(3):406-13. PubMed ID: 9301530
[TBL] [Abstract][Full Text] [Related]
30. The superantigenic activity of streptococcal pyrogenic exotoxin B is independent of the protease activity.
Eriksson A; Norgren M
FEMS Immunol Med Microbiol; 1999 Sep; 25(4):355-63. PubMed ID: 10497866
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A.
Kline JB; Collins CM
Infect Immun; 1996 Mar; 64(3):861-9. PubMed ID: 8641793
[TBL] [Abstract][Full Text] [Related]
32. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II.
Stohl W; Xu D; Zang S; Kim KS; Li L; Hanson JA; Stohlman SA; David CS; Jacob CO
Int Immunol; 2001 Oct; 13(10):1291-300. PubMed ID: 11581174
[TBL] [Abstract][Full Text] [Related]
33. Clonal heterogeneity of superantigen reactivity in human V beta 6+ T cell clones. Limited contributions of V beta sequence polymorphisms.
Goronzy JJ; Oppitz U; Weyand CM
J Immunol; 1992 Jan; 148(2):604-11. PubMed ID: 1530864
[TBL] [Abstract][Full Text] [Related]
34. Streptococcal Pyrogenic Exotoxin A-Stimulated Monocytes Mediate Regulatory T-Cell Accumulation through PD-L1 and Kynurenine.
Giesbrecht K; Förmer S; Sähr A; Heeg K; Hildebrand D
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412561
[TBL] [Abstract][Full Text] [Related]
35. Mutations affecting MHC class II binding of the superantigen streptococcal erythrogenic toxin A.
Hartwig UF; Fleischer B
Int Immunol; 1993 Aug; 5(8):869-75. PubMed ID: 8398982
[TBL] [Abstract][Full Text] [Related]
36. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
37. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.
Watanabe-Ohnishi R; Aelion J; LeGros L; Tomai MA; Sokurenko EV; Newton D; Takahara J; Irino S; Rashed S; Kotb M
J Immunol; 1994 Feb; 152(4):2066-73. PubMed ID: 8120408
[TBL] [Abstract][Full Text] [Related]
38. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action.
Li PL; Tiedemann RE; Moffat SL; Fraser JD
J Exp Med; 1997 Aug; 186(3):375-83. PubMed ID: 9236189
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
Davison S; Allen M; Vaughan R; Barker J
Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
[TBL] [Abstract][Full Text] [Related]
40. Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF).
Eriksson A; Holm SE; Norgren M
Microb Pathog; 1998 Nov; 25(5):279-90. PubMed ID: 9878456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
